Psoriasis treatment and skin color change study
Treatments studied
Part of Skin clinical trials.
This study tests a cream for psoriasis to see if it helps prevent or reduce changes in skin color (dark or light patches) that can happen after psoriasis clears. It may be a good fit if you have medium to dark skin and your psoriasis is stable.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have medium to dark skin (Fitzpatrick skin type 3 or higher).
- You have been diagnosed with psoriasis (ICD10 code L40.9).
- Your psoriasis is stable—you've been on the same treatment (like a biologic) for at least 3 months before starting the study.
- You do not have other skin pigment issues that, in the doctor's opinion, would make it hard to see the results.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing how well a topical betamethasone (a steroid cream) works for psoriasis. It is designed for people who have psoriasis on their skin and can use a smartphone app to track their progress.
This trial compares a new topical cream called tapinarof against a standard steroid cream (betamethasone) for treating moderate plaque psoriasis. Researchers want to see which treatment works better and is safer for people with psoriasis affecting a limited area of skin.
This study tests whether a new ointment called RSS0393 can safely and effectively treat plaque psoriasis (a common skin condition causing red, scaly patches). You would apply it to affected skin areas and be compared to people using a placebo (inactive cream) to see if the treatment works.
This trial tests how safe and how the body handles (pharmacokinetics) a psoriasis lotion called IDP-122 when used in children with plaque psoriasis. You may be able to join if your child has a suitable amount of plaque psoriasis and can follow safety rules during the study.
This trial tests a new medication, CBP-0276, to see if it improves psoriasis symptoms and quality of life. It is for people with moderate to severe plaque psoriasis who might need stronger treatment.
This study follows people starting a new advanced psoriasis treatment to see how well it works over 16 weeks. You'll have three office visits with your dermatologist, and researchers will track your skin improvement to help understand which treatments work best for different patients.
Hear when a new ICD10 Code L40.9 for Psoriasis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.